Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin post-exposure prophylaxis for COVID-19 close contacts
ACTRN12621001535864Phase 3Completed
- Sponsor
- Monash University
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ivermectin in coronavirus disease 2019 (COVID-19), sponsored by Monash University. Started Mar 2022; status: completed.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ACTRN12621001535864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001535864.